Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
Clinical trial NCT07472621 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07472621
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-10
- Primary completion
- 2027-03-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.